New pharmacy player has big plans

Share this article:
A start-up institutional pharmacy company could soon become the market's No. 3 player, according to its executives. The parent group of Golden Living officially launched AlixaRx with predictions it could become a $250 million per year business within 18 months. Ultimately capturing one-fifth or more of the 16,000-nursing home market is a distinct possibility, said AlixaRx President Larry Deans: “If we had 20% of market share [within five years], right now that would be a good goal to shoot for. We believe providers have a need for this service.” AlixaRx's unveiling comes at the detriment of PharMerica, which is losing the Golden Living contracts, company officials said. PharMerica currently has about 20% of the long-term care institutional pharmacy market, which has put it second behind leader Omnicare, which commands approximately 60% of the market, Deans said.
Share this article:

More in Products

LeadingAge's CAST releases EHR matrix selection tool

LeadingAge's Center for Aging Services Technologies released its 2014 version of a tool to let long-term providers choose the best electronic health record for their facility.

New magnetic badges debut

New magnetic badges debut

Imprint Plus has introduced The Mighty Badge name badge kit, which allows users to create reusable but personalized badges.

Hollister Incorporated celebrates antibacterial foam dressing

Hollister Incorporated celebrates antibacterial foam dressing ...

Hollister Incorporated's new Hydrofera Blue Ready antibacterial foam dressing has been named a "Top 10 Innovation in Podiatry" according to the Podiatry Today journal, as well as a "Top Innovation ...